Article
Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.
Leukemia - 1 Jul 2004
Suvannasankha A, Minderman H, O'Loughlin K L, Nakanishi T, Greco W R, Ross D D, Baer M R
Abstract excerpt
Data on breast cancer resistance protein (BCRP, MXR, ABCG2) expression in acute myeloid leukemia (AML) have been inconsistent, possibly due to use of different assays in different studies. BCRP mRNA was studied by the reverse-transcription polymerase chain reaction and BCRP protein expression (BXP-21, BXP-34 or anti-ABCG2 antibody, with anti-CD34 and anti-CD33) and function (fumitremorgin C modulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
